top of page

HELP 4 HD INTERNATIONAL

Stand Up Speak Up 4 HD 🎉 Click Here

Search

Living at Risk: Navigating Life with Huntington's Disease in the Family

katrina4384

13 minutes ago

0 min read

Recent Posts

Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington’s Disease Patients

Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington’s Disease Patients

Prilenia Appoints Frederick (Rick) Munschauer, MD, FAAN, as Chief Medical Officer

Prilenia Appoints Frederick (Rick) Munschauer, MD, FAAN, as Chief Medical Officer

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

Comments

bottom of page